MISSION Therapeutics Companies
MISSION Therapeutics is a biotechnology company that specializes in developing drugs targeting deubiquitylating enzymes (DUBs) for the treatment of various diseases, including Parkinson's. They have a rich pipeline of first-in-class therapeutics that selectively target specific disease-associated DUBs, such as USP30. With a collaborative and science-driven culture, they have strong links to key academic and research centers. Their goal is to translate scientific advances into transformative therapies and make a positive impact on the lives of patients suffering from serious diseases.
Headquarters:
Cambridge, Cambridgeshire, United Kingdom
Founded Date:
2011
Employee Number:
11-50
Industry:
Advanced Longevity (R&D)
Technology:
Advanced and Next Generation Therapies (Various)
Number Of Exists:
N/A